Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season

被引:111
|
作者
Belongia, Edward A. [1 ]
Sundaram, Maria E. [1 ]
McClure, David L. [1 ]
Meece, Jennifer K. [1 ]
Ferdinands, Jill [2 ,3 ]
VanWormer, Jeffrey J. [1 ]
机构
[1] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA
[2] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA
[3] Battelle Mem Inst, Atlanta, GA USA
关键词
Influenza; Influenza vaccine; Immunity; Vaccine effectiveness; EFFICACY; ANTIBODY;
D O I
10.1016/j.vaccine.2014.06.052
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Recent studies have suggested that vaccine-induced protection against influenza may decline within one season. We reanalyzed data from a study of influenza vaccine effectiveness to determine if time since vaccination was an independent predictor of influenza A (H3N2). Methods: Patients with acute respiratory illness were actively recruited during the 2007-2008 season. Respiratory swabs were tested for influenza, and vaccination dates were determined by a validated immunization registry. The association between influenza RT-PCR result and vaccination interval (days) was examined using multivariable logistic regression, adjusting for calendar time, age and other confounders. Results: There were 629 vaccinated participants, including 177 influenza A (H3N2) cases and 452 test negative controls. The mean (SD) interval from vaccination to illness onset was 101.7 (25.9) days for influenza cases and 93.0 (29.9) days for controls. There was a significant association between vaccination interval and influenza result in the main effects model. The adjusted odds ratio (a0R) for influenza was 1.12 (CI 1.01, 1.26) for every 14 day increase in the vaccination interval. Age modified the association between vaccination interval and influenza (p = 0.005 for interaction). Influenza was associated with increasing vaccination interval in young children and older adults, but not in adolescents or non-elderly adults. Similar results were found when calendar week of vaccine receipt was assessed as the primary exposure variable. Conclusions: Identification of influenza A (H3N2) was associated with increasing time since vaccination among young children and older adults during a single influenza season. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 50 条
  • [1] Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15
    Gherasim, Alin
    Pozo, Francisco
    de Mateo, Salvador
    Aspiritxaga Gamarra, Inma
    Garcia-Cenoz, Manuel
    Vega, Tomas
    Martinez, Eva
    Gimenez, Jaume
    Castrillejo, Daniel
    Larrauri, Amparo
    VACCINE, 2016, 34 (20) : 2371 - 2377
  • [2] Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection
    Domnich, Alexander
    Orsi, Andrea
    Signori, Alessio
    Chironna, Maria
    Manini, Ilaria
    Napoli, Christian
    Rizzo, Caterina
    Panatto, Donatella
    Icardi, Giancarlo
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 380 - 388
  • [3] Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season
    Price, Ashley M.
    Flannery, Brendan
    Talbot, H. Keipp
    Grijalva, Carlos G.
    Wernli, Karen J.
    Phillips, C. Hallie
    Monto, Arnold S.
    Martin, Emily T.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Mutnal, Manohar
    Geffel, Krissy Moehling
    Nowalk, Mary Patricia
    Tartof, Sara Y.
    Florea, Ana
    McLean, Callie
    Kim, Sara S.
    Patel, Manish M.
    Chung, Jessie R.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) : 1358 - 1363
  • [4] Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017
    Chiu, Susan S.
    Kwan, Mike Y. W.
    Feng, Shuo
    Wong, Joshua S. C.
    Leung, Chi-Wai
    Chan, Eunice L. Y.
    Chan, Kwok-Hung
    Ng, Tak-Keung
    To, Wing-Kin
    Cowling, Benjamin J.
    Peiris, J. S. Malik
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (09) : 1365 - 1371
  • [5] Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
    McLean, Huong Q.
    Thompson, Mark G.
    Sundaram, Maria E.
    Meece, Jennifer K.
    McClure, David L.
    Friedrich, Thomas C.
    Belongia, Edward A.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (10) : 1375 - 1385
  • [6] Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan
    Sugaya, N.
    Shinjoh, M.
    Kawakami, C.
    Yamaguchi, Y.
    Yoshida, M.
    Baba, H.
    Ishikawa, M.
    Kono, M.
    Sekiguchi, S.
    Kimiya, T.
    Mitamura, K.
    Fujino, M.
    Komiyama, O.
    Yoshida, N.
    Tsunematsu, K.
    Narabayashi, A.
    Nakata, Y.
    Sato, A.
    Taguchi, N.
    Fujita, H.
    Toki, M.
    Myokai, M.
    Ookawara, I.
    Takahashi, T.
    EUROSURVEILLANCE, 2016, 21 (42) : 2 - 14
  • [7] Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022
    Tenforde, Mark W.
    Patel, Manish M.
    Lewis, Nathaniel M.
    Adams, Katherine
    Gaglani, Manjusha
    Steingrub, Jay S.
    Shapiro, Nathan, I
    Duggal, Abhijit
    Prekker, Matthew E.
    Peltan, Ithan D.
    Hager, David N.
    Gong, Michelle N.
    Exline, Matthew C.
    Ginde, Adit A.
    Mohr, Nicholas M.
    Mallow, Christopher
    Martin, Emily T.
    Talbot, H. Keipp
    Gibbs, Kevin W.
    Kwon, Jennie H.
    Chappell, James D.
    Halasa, Natasha
    Lauring, Adam S.
    Lindsell, Christopher J.
    Swan, Sydney A.
    Hart, Kimberly W.
    Womack, Kelsey N.
    Baughman, Adrienne
    Grijalva, Carlos G.
    Self, Wesley H.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (06) : 1030 - 1037
  • [8] Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine Status
    Zhong, Shuyi
    Ng, Tiffany W. Y.
    Skowronski, Danuta M.
    Iuliano, A. Danielle
    Leung, Nancy H. L.
    Perera, Ranawaka A. P. M.
    Ho, Faith
    Fang, Vicky J.
    Tam, Yat Hung
    Ip, Dennis K. M.
    Havers, Fiona G.
    Fry, Alicia M.
    Aziz-Baumgartner, Eduardo
    Barr, Ian G.
    Peiris, Malik
    Thompson, Mark G.
    Cowling, Benjamin J.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (05) : 1451 - 1459
  • [9] T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults
    Haralambieva, Iana H.
    Quach, Huy Quang
    Ovsyannikova, Inna G.
    Goergen, Krista M.
    Grill, Diane E.
    Poland, Gregory A.
    Kennedy, Richard B.
    VIRUSES-BASEL, 2022, 14 (12):
  • [10] Influenza Vaccine Effectiveness: Defining the H3N2 Problem
    Belongia, Edward A.
    McLean, Huong Q.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (10) : 1817 - 1823